Mary Beth Kerrigan

Member

Mary Beth's general corporate and business practice focuses on representing technology-based companies from startup through liquidity event. Her practice includes advising clients with respect to angel financings, venture capital financings and mergers and acquisitions. She also provides general corporate advice to her clients on such matters as capital structure, corporate governance, joint ventures, strategic alliances, executive compensation and intellectual property. In addition to representing companies, Mary Beth also represents venture capital funds and other institutional investors in their investments in portfolio companies.

Mary Beth is listed in the Chambers USA Guide to America's Leading Lawyers for Business for distinction in private equity law. She is also named as a 2007 Massachusetts SuperLawyers Rising Star for Business/Corporate Law as published in Boston magazine.

Prior to joining Morse, Barnes-Brown & Pendleton, Mary Beth was an associate in the business law department of Hutchins, Wheeler & Dittmar, Boston.

Mary Beth is a 1989 cum laude graduate of Tufts University and a magna cum laude 1992 graduate of the New England School of Law, where she was executive lead articles editor for the New England Law Review.

Representative Clients and Done Deals

Acted as outside counsel for:

Network security company (for more than 10 years): Represented client in connection with several rounds of venture capital financing exceeding $100 million.
Revenue recognition software company (for over 10 years): Represented client in connection with several rounds of venture capital financing exceeding $30 million.
Display technology company: Represented client in connection with several rounds of venture capital financing exceeding $25 million.
Healthcare software company: Represented client in connection with several rounds of venture capital financing exceeding $20 million.
Wireless test solutions company: Represented client in connection with several rounds of venture capital financing exceeding $25 million.
Care management solutions company: Represented client in connection with several rounds of venture capital financing exceeding $15 million.
Data integration company: Represented client in connection with two rounds of venture capital financing exceeding $15 million.
Data migration company: Represented client in connection with several rounds of venture capital financing exceeding $5 million.
Healthcare software company: Represented client in connection with several rounds of venture capital financing exceeding $12 million.
Diagnostic testing company: Represented client in connection with several rounds of venture capital financing exceeding $10 million.
Biometric company: Represented client in connection with several rounds of venture capital financing exceeding $8 million.

Also represented:

Public company in connection with the sale of substantially all of its assets for approximately $27 million.
Venture capital firm in connection with two rounds of financing in Canadian portfolio company.
Venture capital firm in connection with several Series A investments in various portfolio companies.
Venture capital firm in connection with several early stage investments in various portfolio companies.

Articles by Mary Beth Kerrigan:

Quoted: Already Have a Buyer? Why You Still Need an Investment Banker

Fiduciary Duty Obligations to Common Stockholders: Management Carve-out Plans

Disclosure Obligations for Stockholder Notices

Motivating and Retaining Employees With a Bonus/Carve-Out Plan

Fiduciary Duties of Board of Directors in Merger

Founders' Equity